TERT Promoter Mutations and Risk of Recurrence in Meningioma-Reference-Cited by-同舟云学术

TERT Promoter Mutations and Risk of Recurrence in Meningioma

Published:2015-12-13 Issue:5 Volume:108 Page:djv377
ISSN:0027-8874
Container-title:Journal of the National Cancer Institute
language:en
Short-container-title:JNCI.J

Author:

Sahm Felix,Schrimpf Daniel,Olar Adriana,Koelsche Christian,Reuss David,Bissel Juliane,Kratz Annekathrin,Capper David,Schefzyk Sebastian,Hielscher Thomas,Wang Qianghu,Sulman Erik P.,Adeberg Sebastian,Koch Arend,Okuducu Ali Fuat,Brehmer Stefanie,Schittenhelm Jens,Becker Albert,Brokinkel Benjamin,Schmidt Melissa,Ull Theresa,Gousias Konstantinos,Friederike Almuth,Lamszus Kessler, Katrin,Debus Jürgen,Mawrin Christian,Kim Yoo-Jin,Simon Matthias,Ketter Ralf,Paulus Werner,Aldape Kenneth D.,Herold-Mende Christel,von Deimling Andreas

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Oncology

Link

http://academic.oup.com/jnci/article-pdf/108/5/djv377/17315257/djv377.pdf

Reference18 articles.

1. The 2007 WHO Classification of Tumours of the Central Nervous System

2. Proposal for a new risk stratification classification for meningioma based on patient age, WHO tumor grade, size, localization, and karyotype

3. Brain Tumors

4. Mitotic Index is an Independent Predictor of Recurrence-Free Survival in Meningioma

5. Highly Recurrent TERT Promoter Mutations in Human Melanoma

Cited by 297 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current immunotherapy techniques in meningioma;Expert Review of Anticancer Therapy;2024-09-04

2. Initial management of newly diagnosed WHO grade 2–3 adult meningioma following surgery: results from the Dutch Brain Tumour Registry (2016–2021);Journal of Neuro-Oncology;2024-08-29

3. The Impact of Molecular and Genetic Analysis on the Treatment of Patients with Atypical Meningiomas;Diagnostics;2024-08-15

4. Diffuse pleural metastasis from atypical meningioma;Respirology Case Reports;2024-07

5. Prognostic Factors and Outcomes in World Health Organization Grade 1 and Grade 2 Intracranial Meningiomas—5-Year Institutional Experience;World Neurosurgery;2024-07